文献速递眼底病与葡萄膜炎神经眼科

ABCA4视网膜病变视觉功能障碍的自然史及其遗传相关性

Natural History of Visual Dysfunction in ABCA4 Retinopathy and Its Genetic Correlates.
PubMed 文献 · Am J Ophthalmol · 2023-05-20

这项前瞻性自然史研究纳入67例ABCA4视网膜病变患者的134只眼,平均随访3.65年,评估微视野和全视野视网膜电图等视觉功能指标检测变化的能力与重测信度。微视野周边敏感度在2年间变化最敏感但仅能在71.6%参与者中记录,5年间暗适应ERG a波振幅对疾病进展敏感。

要点

  • 微视野周边敏感度(η2=0.73)和平均敏感度(η2=0.62)在2年间变化最敏感,但仅71.6%参与者可记录。
  • 5年间暗适应ERG a波振幅(如DA 30 a波η2=0.54)对疾病进展敏感,或可支持覆盖全谱系的临床试验设计。
  • 基因型解释了ERG评估的发病年龄变异的较大比例(校正R2=0.73)。

核心结论

  • 微视野临床结局评估对变化最敏感但仅能在部分参与者中获取,5年间ERG DA 30 a波振幅对疾病进展敏感,可能支持覆盖整个ABCA4视网膜病变谱系的临床试验设计。

研究设计与样本

  • 前瞻性自然史研究(NCT01736293),从三级转诊中心招募至少携带1个致病性ABCA4变异且临床表型符合ABCA4视网膜病变的患者。
  • 共纳入67例参与者的134只眼,平均随访3.65年,进行纵向多维度功能测试(最佳矫正视力、低视力剑桥色觉测试、微视野、全视野视网膜电图)。

主要发现

  • 微视野指标仅能在71.6%的参与者中记录。
  • 基因型解释了基于ERG的疾病发病年龄变异的较大比例(校正R2=0.73)。

局限性

  • 微视野指标仅能在71.6%的参与者中记录,限制了其作为全体患者结局评估的适用性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To systematically assess the ability to detect change and retest reliability for a panel of visual function assessments in ABCA4 retinopathy. DESIGN: Prospective natural history study (NCT01736293). METHODS: Patients with at least 1 documented pathogenic ABCA4 variant and a clinical phenotype consistent with ABCA4 retinopathy were recruited from a tertiary referral center. Participants underwent longitudinal, multifaceted functional testing, including measures of function at fixation (best-corrected visual acuity, low-vision Cambridge Color Test), macular function (microperimetry), and retina-wide function (full-field electroretinography [ERG]). Two- and 5-year ability to detect change was determined based on the η2 statistic. RESULTS: A total of 134 eyes from 67 participants with a mean follow-up of 3.65 years were included. In the 2-year interval, the microperimetry-derived perilesional sensitivity (η2 of 0.73 [0.53, 0.83]; -1.79 dB/y [-2.2, -1.37]) and mean sensitivity (η2 of 0.62 [0.38, 0.76]; -1.28 dB/y [-1.67, -0.89]) showed most change over time, but could only be recorded in 71.6% of the participants. In the 5-year interval, the dark-adapted ERG a- and b-wave amplitude showed marked change over time as well (eg, DA 30 a-wave amplitude with an η2 of 0.54 [0.34, 0.68]; -0.02 log10(µV)/y [-0.02, -0.01]). The genotype explained a large fraction of variability in the ERG-based age of disease initiation (adjusted R2 of 0.73) CONCLUSIONS: Microperimetry-based clinical outcome assessments were most sensitive to change but could only be acquired in a subset of participants. Across a 5-year interval, the ERG DA 30 a-wave amplitude was sensitive to disease progression, potentially allowing for more inclusive clinical trial designs encompassing the whole ABCA4 retinopathy spectrum.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Pfau M, Huryn LA, Boyle MP, et al. Natural History of Visual Dysfunction in ABCA4 Retinopathy and Its Genetic Correlates. Am J Ophthalmol. 2023. PMID: 37211138. doi:10.1016/j.ajo.2023.05.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。